Overview

PET Imaging of PARP Activity in Cancer

Status:
Enrolling by invitation
Trial end date:
2023-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to determine the feasibility of using positron emission tomography (PET) imaging technology to image cancer with [18F]FluorThanatrace ([18F]FTT), a new radioactive tracer compound that has been developed that images poly(ADP-ribose) polymerase 1 (PARP-1) activity.
Phase:
Early Phase 1
Details
Lead Sponsor:
Washington University School of Medicine